Pisa syndrome associated with mirtazapine: a case report
| Autor: | Naotsugu Hirabayashi, Naoko Satake, Kazuyuki Nakagome, Maki K. Yamada, Harumasa Takano, Mitsutoshi Okazaki, Yuji Yamada |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Drug
Side effect Bipolar disorder media_common.quotation_subject Mirtazapine Case Report Pharmacology Noradrenergic and specific serotonergic antidepressant 03 medical and health sciences 0302 clinical medicine lcsh:RA1190-1270 medicine Humans Side-effects Pharmacology (medical) 030212 general & internal medicine Adverse effect media_common Aged lcsh:Toxicology. Poisons Dystonia business.industry Dopaminergic lcsh:RM1-950 Syndrome medicine.disease Antidepressive Agents Pisa syndrome lcsh:Therapeutics. Pharmacology Female business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-3 (2018) BMC Pharmacology & Toxicology |
| ISSN: | 2050-6511 |
| DOI: | 10.1186/s40360-018-0272-8 |
| Popis: | Background Mirtazapine is a noradrenergic and specific serotonergic antidepressant; its pharmacological profile indicates a low risk for dopaminergic adverse effects. To date, there has been only a single case report of Pisa syndrome associated with mirtazapine. Case presentation The authors report a case involving a 79-year-old woman with bipolar disorder, in whom Pisa syndrome occurred after introduction of mirtazapine, and completely disappeared 3 days after suspension of the drug. Conclusions Aspects of this particular case suggest that Pisa syndrome is a possible side effect of Mirtazapine. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink